The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

AG-K-61384     disodium; gold(+1) cation; 2...

Synonyms: CTK4I1295, AR-1J1367, FT-0636762, AC1L2G6B, I09-3656, ...
This record was replaced with 6268.
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Monomercaptosuccinic acid


High impact information on Monomercaptosuccinic acid


Chemical compound and disease context of Monomercaptosuccinic acid


Biological context of Monomercaptosuccinic acid


Anatomical context of Monomercaptosuccinic acid


Associations of Monomercaptosuccinic acid with other chemical compounds


Gene context of Monomercaptosuccinic acid


Analytical, diagnostic and therapeutic context of Monomercaptosuccinic acid


  1. Diffuse pulmonary injury associated with gold treatment. Winterbauer, R.H., Wilske, K.R., Wheelis, R.F. N. Engl. J. Med. (1976) [Pubmed]
  2. Decreased spleen size and increased neutrophils in patients with Felty syndrome. Effects of gold sodium thiomalate therapy. Hurd, E.R., Cheatum, D.E. JAMA (1976) [Pubmed]
  3. Light- and electron-microscopical study of a case of gold salt-induced hepatotoxicity. Fleischner, G.M., Morecki, R., Hanaichi, T., Hayashi, H., Quintana, N., Sternlieb, I. Hepatology (1991) [Pubmed]
  4. Acute myocardial infarction following gold sodium thiomalate induced vasomotor (nitritoid) reaction. Gottlieb, N.L., Brown, H.E. Arthritis Rheum. (1977) [Pubmed]
  5. Gold sodium thiomalate selectivity inhibits interleukin-5-mediated eosinophil survival. Suzuki, S., Okubo, M., Kaise, S., Ohara, M., Kasukawa, R. J. Allergy Clin. Immunol. (1995) [Pubmed]
  6. Effect of gold sodium thiomalate and its thiomalate component on the in vitro expression of endothelial cell adhesion molecules. Newman, P.M., To, S.S., Robinson, B.G., Hyland, V.J., Schrieber, L. J. Clin. Invest. (1994) [Pubmed]
  7. Immunomodulatory effects of therapeutic gold compounds. Gold sodium thiomalate inhibits the activity of T cell protein kinase C. Hashimoto, K., Whitehurst, C.E., Matsubara, T., Hirohata, K., Lipsky, P.E. J. Clin. Invest. (1992) [Pubmed]
  8. Helicobacter pylori and peptic ulcers in rheumatoid arthritis patients receiving gold, sulfasalazine, and nonsteroidal anti-inflammatory drugs. Taha, A.S., Sturrock, R.D., Russell, R.I. Am. J. Gastroenterol. (1992) [Pubmed]
  9. A modified mouse air pouch model for evaluating the effects of compounds on granuloma induced cartilage degradation. Bottomley, K.M., Griffiths, R.J., Rising, T.J., Steward, A. Br. J. Pharmacol. (1988) [Pubmed]
  10. Slow acting antirheumatic drugs in patients with juvenile rheumatoid arthritis--evaluated in a randomized, parallel 50-week clinical trial. Kvien, T.K., Høyeraal, H.M., Sandstad, B. J. Rheumatol. (1985) [Pubmed]
  11. Mesangial glomerulopathy in rheumatoid arthritis patients. Clinical follow-up and relation to antirheumatic therapy. Korpela, M., Mustonen, J., Pasternack, A., Helin, H. Nephron (1991) [Pubmed]
  12. Protective effects of chelating agents against renal toxicity of gold sodium thiomalate in rats. Kojima, S., Takahashi, Y., Kiyozumi, M., Tagawa, Y. Arch. Toxicol. (1991) [Pubmed]
  13. Biologic actions and pharmacokinetic studies of auranofin. Walz, D.T., DiMartino, M.J., Griswold, D.E., Intoccia, A.P., Flanagan, T.L. Am. J. Med. (1983) [Pubmed]
  14. Gold sodium thiomalate down-regulates intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression on vascular endothelial cells. Koike, R., Miki, I., Otoshi, M., Totsuka, T., Inoue, H., Kase, H., Saito, I., Miyasaka, N. Mol. Pharmacol. (1994) [Pubmed]
  15. The effect of gold sodium thiomalate in adult Swiss/A2G mice infected with togaviruses and flaviviruses. Mehta, S., Webb, H.E. J. Gen. Virol. (1987) [Pubmed]
  16. Heme metabolism in the fetoplacental unit and neonatal livers during lactation: effect of gold sodium thiomalate. Eiseman, J.L., Alvares, A.P. J. Pharmacol. Exp. Ther. (1980) [Pubmed]
  17. Antirheumatic drug effects on neutrophil response to chemotactic factors: a comparison of analytical techniques. Turner, R.A., Johnson, J.A., Semble, E.L. Proc. Soc. Exp. Biol. Med. (1983) [Pubmed]
  18. Inhibition of human endothelial cell proliferation by gold compounds. Matsubara, T., Ziff, M. J. Clin. Invest. (1987) [Pubmed]
  19. Peripheral lymphocyte depletion in gold sodium thiomalate-treated rheumatoid arthritis patients. Lundberg, M.S., Cannon, G.W., Ward, J.R. Arthritis Rheum. (1988) [Pubmed]
  20. Effects of gold sodium thiomalate on functional correlates of human monocyte maturation. Littman, B.H., Hall, R.E. Arthritis Rheum. (1985) [Pubmed]
  21. Suppression of interleukin-2 and interleukin-2 receptor biosynthesis by gold compounds in in vitro activated human peripheral blood mononuclear cells. Sfikakis, P.P., Souliotis, V.L., Panayiotidis, P.P. Arthritis Rheum. (1993) [Pubmed]
  22. Alterations in macrophage collagenase secretion induced by gold sodium thiomalate. Spalding, D.M., Darby, W.L., Heck, L.W. Arthritis Rheum. (1986) [Pubmed]
  23. Effects of gold sodium thiomalate on interferon stimulation of C2 synthesis and HLA-DR expression by human monocytes. Sanders, K.M., Carlson, P.L., Littman, B.H. Arthritis Rheum. (1987) [Pubmed]
  24. Effects of gold sodium thiomalate and tenidap sodium (CP-66,248-2) on a model of macrophage differentiation using HL-60 cells. Littman, B.H., Carlson, P.L., Loose, L.D., Sanders, K.M. Arthritis Rheum. (1990) [Pubmed]
  25. Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. Subsets of responses. Ward, J.R., Williams, H.J., Boyce, E., Egger, M.J., Reading, J.C., Samuelson, C.O. Am. J. Med. (1983) [Pubmed]
  26. Radiographic outcome after three years of patients with early erosive rheumatoid arthritis treated with intramuscular methotrexate or parenteral gold. Extension of a one-year double-blind study in 174 patients. Rau, R., Herborn, G., Menninger, H., Sangha, O. Rheumatology (Oxford, England) (2002) [Pubmed]
  27. Effects of combinations of anti-rheumatic drugs on the production of vascular endothelial growth factor and basic fibroblast growth factor in cultured synoviocytes and patients with rheumatoid arthritis. Nagashima, M., Wauke, K., Hirano, D., Ishigami, S., Aono, H., Takai, M., Sasano, M., Yoshino, S. Rheumatology (Oxford, England) (2000) [Pubmed]
  28. The modulation of interleukin 1 production by interferon gamma, and the inhibitory effects of gold compounds. Harth, M., McCain, G.A., Cousin, K. Immunopharmacology (1990) [Pubmed]
  29. Gold sodium thiomalate suppresses the differentiation and function of human dendritic cells from peripheral blood monocytes. Wang, Z.Y., Morinobu, A., Kawano, S., Saegusa, J., Wang, B., Kumagai, S. Clinical and experimental rheumatology. (2002) [Pubmed]
  30. Monocyte chemoattractant protein 1 and interleukin 8 production by rheumatoid synoviocytes. Effects of anti-rheumatic drugs. Loetscher, P., Dewald, B., Baggiolini, M., Seitz, M. Cytokine (1994) [Pubmed]
  31. Gold does not alter the arthritic, humoral, or cellular responses in rats with type II collagen-induced arthritis. McCune, W.J., Trentham, D.E., David, J.R. Arthritis Rheum. (1980) [Pubmed]
  32. Auranofin versus injectable gold. Comparison of pharmacokinetic properties. Blocka, K. Am. J. Med. (1983) [Pubmed]
  33. Effects of auranofin and myochrysine on intestinal transport and morphology in the rat. Ammon, H.V., Fowle, S.A., Cunningham, J.A., Komorowski, R.A., Loeffler, R.F. Gut (1987) [Pubmed]
  34. Antiarthritic properties and unique pharmacologic profile of a potential chrysotherapeutic agent: S K & F D-30162. Walz, D.T., DiMartino, M.J., Chakrin, L.W., Sutton, B.M., MISHER, A. J. Pharmacol. Exp. Ther. (1976) [Pubmed]
WikiGenes - Universities